President Donald Trump’s recent claim that the common pain reliever acetaminophen “causes autism” has ignited a storm of controversy at the intersection of medicine and politics. Speaking at a White House event alongside Health and Human Services Secretary Robert F. Kennedy Jr., Trump urged pregnant women to avoid the drug, better known under the Tylenol brand. The controversy not only underscores the challenges of communicating uncertain science but also raises pressing questions about how political leaders shape public trust in health guidance.

Read More